…t regimens targeting immune checkpoint inhibitors, including in hepatocellular carcinoma (HCC).1 Genetic and epigenetic intratumour heterogeneity, as we…
Hepatocellular carcinoma
This disease is selected. Its supporting articles are shown below.
Articles mentioning Hepatocellular carcinoma
253 articles · page 8 of 22…ctive anti-HCV treatment and the disuse of protease inhibitors, HIV infection was no more associated to higher risk of rejection. H…
…Background Chronic Hepatitis Delta (HDV) is the most severe form of viral hepatitis. The entry inhibitor…
…ding inflammatory bowel disease, eosinophilic oesophagitis, and hepatocellular carcinoma, are anatomically localized, yet are still predominantly treate…
…nsformative impact of immune checkpoint inhibitors in oncology, hepatocellular carcinoma (HCC) remains stubbornly resistant in many patients, with durab…
…tegy for recurrence prevention following curative treatment for hepatocellular carcinoma (HCC), including radiotherapy, remains a critical unmet clinica…
… transarterial radioembolization (TARE) is well established for hepatocellular carcinoma to deliver high dose, short range β-brachytherapy in the form o…
…Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortalit…
…nd HCV contribute to approximately three-quarters of the global HCC burden. These data can inform viral hepatitis prevention strate…
…on, carrying substantial risks of liver fibrosis, cirrhosis and hepatocellular carcinoma. Fewer than 20% of patients receiving nucleos(t)ide analogues o…
…k in the progression from chronic liver injury to cirrhosis and hepatocellular carcinoma (HCC). Activated hepatic stellate cells (HSCs) play a central r…
…ackground Immune checkpoint inhibitors (ICIs) enable successful hepatocellular carcinoma (HCC) downstaging or bridging for liver transplantation (LT) bu…